119 related articles for article (PubMed ID: 3776907)
1. Treatment of carcinoma of the fallopian tube using cisplatin, doxorubicin, and cyclophosphamide.
Jacobs AJ; McMurray EH; Parham J; Kao MS; Galakatos AE; Perez CA; Camel HM
Am J Clin Oncol; 1986 Oct; 9(5):436-9. PubMed ID: 3776907
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Morris M; Gershenson DM; Burke TW; Kavanagh JJ; Silva EG; Wharton JT
Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
[TBL] [Abstract][Full Text] [Related]
3. Treatment of fallopian tube carcinoma with cyclophosphamide, adriamycin, and cisplatin.
Cormio G; Maneo A; Gabriele A; Zanetta G; Losa G; Lissoni A
Am J Clin Oncol; 1997 Apr; 20(2):143-5. PubMed ID: 9124187
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary fallopian tube carcinoma with cisplatin-containing chemotherapy.
Pectasides D; Barbounis V; Sintila A; Varthalitis I; Dimitriadis M; Athanassiou A
Am J Clin Oncol; 1994 Feb; 17(1):68-71. PubMed ID: 8311012
[TBL] [Abstract][Full Text] [Related]
5. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
6. Results of chemotherapy in advanced carcinoma of the fallopian tube.
Peters WA; Andersen WA; Hopkins MP
Cancer; 1989 Mar; 63(5):836-8. PubMed ID: 2914291
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the fallopian tube: report of a case with an unusual pattern of metastasis and response to combination chemotherapy.
Young JA; Kossman CR; Green MR
Gynecol Oncol; 1984 Feb; 17(2):238-40. PubMed ID: 6546733
[TBL] [Abstract][Full Text] [Related]
8. Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy.
Maxson WZ; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
Gynecol Oncol; 1987 Mar; 26(3):305-13. PubMed ID: 3557196
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Pecorelli S; Vergote I; Curran D; Wagener DJ; Kobierska A; Bolis G; Bokkel-Huinink WT; Lacave AJ; Madronal C; Forn M; de Oliveira CF; Mangioni C; Nooij MA; Goupil A; Kerbrat P; Marth CH; Tumolo S; Herben MG; Zanaboni F; Vermorken JB
Eur J Gynaecol Oncol; 2001; 22(3):187-93. PubMed ID: 11501769
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy for advanced carcinoma of the fallopian tube.
Deppe G; Bruckner HW; Cohen CJ
Obstet Gynecol; 1980 Oct; 56(4):530-2. PubMed ID: 7191548
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy for mixed müllerian tumor of the Fallopian tube.
Deppe G; Zbella E; Friberg J; Thomas W
Cancer; 1984 Oct; 54(8):1517-20. PubMed ID: 6089992
[TBL] [Abstract][Full Text] [Related]
12. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
13. High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
Hainsworth JD; Burnett LS; Jones HW; Grosh WW; Johnson DH; Greco FA
J Clin Oncol; 1990 Mar; 8(3):502-8. PubMed ID: 2407811
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center.
Wils J; van Geuns H
Am J Clin Oncol; 1989 Jun; 12(3):251-4. PubMed ID: 2658540
[TBL] [Abstract][Full Text] [Related]
15. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
[TBL] [Abstract][Full Text] [Related]
16. Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.
Pectasides D; Pectasides E; Papaxoinis G; Andreadis C; Papatsibas G; Fountzilas G; Pliarchopoulou K; Macheras A; Aravantinos G; Economopoulos T
Gynecol Oncol; 2009 Oct; 115(1):97-101. PubMed ID: 19615725
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube.
Barakat RR; Rubin SC; Saigo PE; Chapman D; Lewis JL; Jones WB; Hakes TB; Markman M; Reichman B; Hoskins WJ
Gynecol Oncol; 1991 Aug; 42(2):156-60. PubMed ID: 1894176
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.
Gemignani ML; Hensley ML; Cohen R; Venkatraman E; Saigo PE; Barakat RR
Gynecol Oncol; 2001 Jan; 80(1):16-20. PubMed ID: 11136563
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.
Cass I; Resnik E; Chambers JT; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE
Gynecol Oncol; 1996 Jun; 61(3):309-14. PubMed ID: 8641607
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients.
Wang PH; Yuan CC; Chao HT; Juang CM; Ng HT
Eur J Gynaecol Oncol; 1998; 19(6):571-4. PubMed ID: 10215444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
